LexaMed Blog

Cleaning Validation for Reusable Medical Devices

Cleaning Validation for Reusable Medical Devices Published:  March 20, 2025 Author:  Anne M. Schuler Topics:  reusable medical devices, cleaning validations, reprocessing of reusable medical devices, end-of-life conditioning, AAMI ST98, ISO 17664, medical device IFU, protein analysis, hemoglobin analysis Related Services:  End-of-life conditioning, 21 CFR 801, instruction for use development Reusable medical devices are devices that health care providers can reprocess and reuse on multiple patients.  If they are not properly reprocessed between use, there is a greater likelihood of microbial transmission and a high risk of infection. Cleaning is the physical removal of soil and contaminants, according to the FDA guidance document Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling Guidance for Industry and Food and Drug Administration Staff effective cleaning should:

Read More »

LexaMed Turnaround Times

LexaMed . Lot Release Testing Turnaround Times Published:  February 18, 2025 Author:  Hayden Rowan Topics:  Medical Device Testing, Pharmaceutical Testing, Lot Release Testing, Turnaround Times Related Services:  Sterility Assurance, USP <71> Bioburden Determinations, ISO 11737-1, Microbial Limits, USP <61>, USP <62>, Bacterial Endotoxin Testing, Limulus Amebocyte Lysate, LAL,  USP <85>, AAMI ST72 At LexaMed, we understand that time is critical. That’s why we pride ourselves on delivering the fastest turnaround times in the industry. Whether it’s sterility, bioburden, or endotoxin testing, we consistently exceed industry standards, ensuring you get the results you need – when you need them. With our advanced technology and expert team, we make speed and accuracy our priority, helping you make quick, informed decisions. Choose LexaMed for all routine testing that

Read More »

MSS Study of Reconstituted or Diluted Drugs

Microbial Stability Study of . Drug Products Published:  February 7, 2025 Author:  Anne M. Schuler Topics:  Microbial stability studies, pharmaceuticals, reconstituted drug products, diluted drug products, microbial contamination, microbial hold time study Related Services:  USP <51>, Antimicrobial Effectiveness Testing Pharmaceutical companies must go to great lengths to produce a drug product that is sterile and safe for use.  When the sterile product is  administered immediately after penetration of the container closure system there is no time for microorganisms which may have entered the   during penetration to grow.  However,  many sterile drug products require reconstitution or dilution in a hospital pharmacy prior to use.  These prepared drugs may then be held for a period of time prior to administration during which time microorganisms have an opportunity

Read More »